Differential Effects of Canonical Androgens and 11-Ketotestosterone on Reproductive Phenotypes and Folliculogenesis in Mouse Model of PCOS

Differential Effects of Canonical Androgens and 11-Ketotestosterone on Reproductive Phenotypes and Folliculogenesis in Mouse Model of PCOS

<b>Background</b>: Polycystic ovary syndrome (PCOS) is a common female endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. While canonical androgens like testosterone (T) and dihydrotestosterone (DHT) are well studied in PCOS pa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Ru Tsai, Yen-Nung Liao, Cheng-Ju Tsai, Yu-Ang Lee, Shih-Min Hsia, Kuo-Chung Lan, Hong-Yo Kang
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Biomedicines
Subjects:	polycystic ovary syndrome hyperandrogenism androgen receptor 11-ketotestosterone
Online Access:	https://www.mdpi.com/2227-9059/13/5/1077
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hyperandrogenism-mediated YAP activation drives ovarian inflammation and pyroptosis in PCOS: implications for follicular dysfunction
by: Tianyue Xu, et al.
Published: (2025-07-01)

Hyperandrogenism as a side effect of anticonvulsants
by: E. V. Tsallagova, et al.
Published: (2018-08-01)

The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data
by: Asmamaw Demis Bizuneh, et al.
Published: (2025-07-01)

The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease
by: So-hyeon Hong, et al.
Published: (2025-08-01)

Impact of polycystic ovary syndrome on the atherogenic plasma index: A retrospective analysis
by: Huseyin Demirci, et al.
Published: (2025-07-01)

SCLEROCYSTIC OVARIES: CURRENT APPROACHES TO THE PROBLEM
by: A. G. Solopova, et al.
Published: (2017-08-01)

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance
by: E. M. Bogatyreva, et al.
Published: (2018-07-01)

Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome
by: Khulood Hussein, et al.
Published: (2023-06-01)

Exploration of the molecular mechanism of melatonin against polycystic ovary syndrome based on a network pharmacology approach and experimental validation
by: Ran Cheng, et al.
Published: (2025-08-01)

Clinical utility of FAI and SHBG in differentiating PCOS from anovulatory cycles in adolescent girls
by: Emre Özer, et al.
Published: (2025-08-01)

Immunohistochemical features of ovarian structure at polycystic ovary syndrom depending on the age
by: I. Yu. Ganzhiy
Published: (2012-12-01)

The roles of MAPK signaling pathway in ovarian folliculogenesis
by: Hong Zhao, et al.
Published: (2025-07-01)

Gut microbiota biodiversity indices as markers of hyperandrogenemia in women of reproductive age
by: I. A. Igumnov, et al.
Published: (2024-09-01)

ABILITY TO RESTORE REPRODUCTIVE SYSTEM IN PATHINTS WITH COMBINED FORM OF HYPERANDROGENISM
by: R. A. Saidova, et al.
Published: (2016-06-01)

Mechanisms of traditional Chinese medicine regulating polycystic ovary syndrome through gut microbiota: a review
by: Xiaomei Jiang, et al.
Published: (2025-08-01)

Frequency of Polycystic Ovary Syndrome and “Being at Risk for Polycystic Ovary Syndrome” in Obese Adolescent Girls in Light of Current Definitions
by: Özlem Yüksel, et al.
Published: (2025-09-01)

Polycystic ovary syndrome - 80 years of research and new directions in the study (literature review)
by: L. V. Damdinova, et al.
Published: (2016-09-01)

Endometrial morphology in women of reproductive age with PCOS
by: E. M. Sharifulin, et al.
Published: (2018-05-01)

Estimation of the hepcidin level and some Biochemical parameters in patients of polycystic ovary Syndrome in Kirkuk city
by: Sherin Bahgat Ayed AL- Tikriti, et al.
Published: (2019-08-01)

Extracellular matrix dysregulation in PCOS: pathogenesis, therapeutic strategies, and innovative technologies
by: Yunxi Liu, et al.
Published: (2025-07-01)

Relative impact of probiotics on improving insulin resistance in women with PCOS: an evaluation with neutrosophic plithogenic statistics
by: Carlos Castañeda Guillot, et al.
Published: (2025-07-01)

Ovarian epigenetics modifications following lifestyle interventions by exercise and alternate-day feeding in letrozole-induced PCOS rats
by: Fatemeh Soltaninejad, et al.
Published: (2025-07-01)

Association between mitochondrial SIRTs (SIRT3, SIRT4, and SIRT5) and PCOS
by: Liying Huang, et al.
Published: (2025-07-01)

Butyric acid ameliorates PCOS-related reproductive dysfunction through gut-brain-ovary axis signaling and ovarian steroidogenic factor activation
by: Xueping Feng, et al.
Published: (2025-07-01)

The correlation between serum fructose levels and pregnancy outcomes in IVF patients with and without PCOS: a case-control study
by: Bowen Zhang, et al.
Published: (2025-03-01)

Knowledge about polycystic ovary syndrome (PCOS), body image, and depression by PCOS status among a sample of US females
by: Brianna M Magnusson, et al.
Published: (2025-09-01)

DRUG THERAPY FOR ANDROGEN-POSITIVE BREAST CANCER
by: A. D. Zikiryakhodjhaev, et al.
Published: (2021-03-01)

Androgens as the “old age stick” in skeletal muscle
by: Giulia Gentile, et al.
Published: (2025-04-01)

Comparison of the Effectiveness of Insulin Sensitizing Agents Metformin and Rosiglitazone in PCOS
by: Rıfat Emral, et al.
Published: (2008-06-01)

“I feel like it gets worse as I get older”: perspectives of peri-postmenopausal women with PCOS
by: Pamela J. Wright, et al.
Published: (2025-08-01)

Physical Activity vs. Pharmacotherapy in PCOS Treatment: A relief of Clinical Evidence on Exercise and Metformine Efficacy
by: Magdalena Bartold, et al.
Published: (2025-08-01)

Soy Isoflavones and PCOS: Role in Hormonal and Metabolic Mechanisms
by: Katarzyna Dereń, et al.
Published: (2025-05-01)

Comparison of the Clinical Outcomes in Women with A or D PCOS Phenotypes versus Single Polycystic Ovary undergoing IVF-ET
by: Fangfang Dai, et al.
Published: (2024-02-01)

Combined Oral Contraceptives for Polycystic Ovary Syndrome: <i>Pro</i> and <i>Contra</i> (Review)
by: I. A. Mazerkina, et al.
Published: (2024-07-01)

KAT2B regulates estradiol synthesis via H3K27ac/PPARα in granulosa cells of PCOS patients
by: Ao Wang, et al.
Published: (2025-07-01)

Design and fabrication of smartphone based single paper lateral flow assay for early detection of PCOS biomarker
by: Aniket Nandi, et al.
Published: (2025-10-01)

Histochemical Effect of Capsaicin Alone or in Combination with The Metformin on Ovaries Structure After Induced a Polycystic Ovary Syndrome by Letrozole in Rats
by: Alia Mohammed Khudier, Karim H. Al-derawi, Labeed A. Al- saad
Published: (2024-03-01)

Effect of COVID-19 on the Role of Renin Enzyme and ACE2 and Hormones in PCOS Females
by: Shaimaa Emad Ali, et al.
Published: (2023-12-01)

Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
by: Xia Sheng, et al.
Published: (2015-04-01)

Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview
by: Saleh Altuwaijri, et al.
Published: (2025-03-01)